Altimmune Inc (NAS:ALT)
$ 8.57 -0.16 (-1.83%) Market Cap: 609.54 Mil Enterprise Value: 471.93 Mil PE Ratio: 0 PB Ratio: 4.57 GF Score: 30/100

Q4 2019 Altimmune Inc Earnings Call Transcript

Mar 27, 2020 / 12:30PM GMT
Release Date Price: $2.85 (-12.31%)
Operator

Greetings. Welcome to Altimmune Year-end 2019 Conference Call. (Operator Instructions) Please note, this conference is being recorded. I will now turn the conference over to your host, Monique Kosse with LifeSci Advisors. Thank you. You may begin.

Monique Kosse
LifeSci Advisors, LLC - MD

Thank you, operator, and thank you, everyone, for participating in today's year-end 2019 earnings conference call. Leading the call today will be Vipin Garg, Chief Executive Officer of Altimmune. Also participating on the call is Will Brown, Chief Financial Officer; Scott Roberts, Chief Scientific Officer; and Scott Harris, Chief Medical Officer. (Operator Instructions)

A press release with the year-end 2019 financial results was issued this morning and can be found on the Investors page of the company's website.

Before we begin, I would like to remind everyone that remarks about future expectations, plans and prospects constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot